The post A practical framework for choosing e-signatures in global trials appeared first on Clinical Trials Arena.
A practical framework for choosing e-signatures in global trials
Sonia Fischer, Director of Product Management, IQVIA, discusses the main considerations when to use QES or AES. Sonia Fischer, Director of Product Management, IQVIA, discusses the main considerations when to use QES or AES. QES is the highest bar available for electronic consent. Credit: khunkornStudio / Shutterstock.com Ask a clinical trial sponsor when to use a qualified e-signature (QES) instead of a standard e-signature (AES), and you’ll usually get one of two answers: “Wherever it’s mandated” or “Everywhere, to be safe.” Both answers are incomplete, and the second one is often expensive. QES is the highest bar available for electronic…
Sonia Fischer, Director of Product Management, IQVIA, discusses the main considerations when to use QES or AES.
Source: Clinical Trials Arena